Dose Response of Whey and Soy Protein Ingestion With and Without Resistance Exercise in Elderly Men (NDC)
Sarcopenia
About this trial
This is an interventional prevention trial for Sarcopenia focused on measuring sarcopenia, muscle, protein, muscle protein synthesis, muscle protein breakdown, whey, soy, casein, dose response, resistance exercise, unilateral, knee extension, whole body protein
Eligibility Criteria
Inclusion Criteria:
- Male
- Aged 60 to 80 years old
- Non-smoker
- Generally healthy and can tolerate the resistance exercise and protein drink
Exclusion Criteria:
- Allergies to whey, casein or soy
- Health problems such as: heart disease, rheumatoid arthritis of the knee joint, diabetes, poor lung function, uncontrolled hypertension, or any health conditions that might put participants at risks for this study
- Failed clearance for exercise participation by their medical doctor
- Failed an exercise stress test
- Taking metformin and/or other medications for the control of blood glucose even though one might not be classified as diabetic
- Taking prescribed blood thinners such as warfarin and heparin but excluding aspirin
- Taking medications for lung and kidney conditions but excluding medication for asthma that is under control
Sites / Locations
- McMaster University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Other
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Control group 0 g protein
10g whey
20g whey
30g whey
40g whey
20g soy
40g soy
Control group in which a placebo drink containing no protein is given following unilateral knee extension exercise
10g whey protein given following unilateral knee extension exercise
20g whey protein given following unilateral knee extension exercise
30g whey protein given following unilateral knee extension exercise
40g whey protein given following unilateral knee extension exercise
20g soy protein given following unilateral knee extension exercise
40g soy protein given following unilateral knee extension exercise